Biological Causes of Treatment-Resistant Depression

 

It is understandable to feel frustrated if the symptoms of depression that you're experiencing haven't responded to medication or counseling. However, it's not uncommon to have depression that doesn't respond to first-line treatments like medication. In fact, about one in three people with depression experience symptoms that do not respond to medication.

 

There are several potential causes of treatment-resistant depression, and one is genetic makeup. The good news is that there are constructive ways to find your own path toward effective symptom treatment—DNA does not define destiny.

We All Respond Differently to Medications

 

You may be familiar with the idea that everyone's responses to medications are different. Imagine that you and a friend are taking the same painkiller after an injury. The resulting levels of that drug and its effect on receptors in your body can vary substantially compared to those in your friend's system, even if you are the same age and weight.

 

Many factors can account for this variability, such as your unique biology, diet, hormonal status, other medications, and liver or kidney issues. Crucially, genetic factors can strongly influence how your body reacts to a given medication. This is because our bodies' enzymes process the medications we take, and our genes influence how these enzymes function. That means our unique genetic blueprint directs how our enzymes break down and process medications.

Genes Can Influence the Effectiveness of Depression Medications

 

There's an important set of enzymes called the cytochrome P450 enzymes that breaks down (metabolizes) many commonly used antidepressants, including selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants. If someone has a genetic variation in these enzymes, these drugs could build up quickly without being broken down, which could lead to side effects. The drugs could also leave the patient's system prematurely before they have a chance to work fully. Both of these situations can contribute to treatment-resistant depression. 

 

In addition, some people have genetic variations in the receptors targeted by common depression medications, which can make these medications less effective.

  • In one meta analysis of people taking SSRIs, symptom improvement was associated with people who had particular variations of a serotonin transporter gene.
  • Similarly, a study of 706 patients found that variations in a gene called UST influenced the response to tricyclic antidepressants, including nortriptyline.
  • Around 70 percent of people with depression have a genetic variation in an enzyme called MTHFR that causes a deficiency of a substance called L-methylfolate. L-methylfolate is important for synthesizing important chemical messengers (neurotransmitters), including dopamine, norepinephrine, and serotonin. Most antidepressants operate on these neurotransmitters, so if they aren't present in high enough quantities, antidepressants won't work as well. Research suggests that treatment with 15 mg a day of L-methylfolate can enhance the synthesis of neurotransmitters and boost the effectiveness of depression treatments.

 

The extent to which genetic diversity affects response to depression medications for most patients is still under debate , and the FDA has advised caution around commercial tests that claim to predict a person's response to medications. Even if a genetic test confirms your susceptibility to developing lower or higher concentrations of a given medication in your blood, that laboratory test cannot forecast how it will function in your brain, and it cannot predict your clinical response in real life. You are more than your DNA.

 

However, this evolving science does suggest that some people with depression may have a genetic variation that could explain why they have not responded well to medications.

Thanks for subscribing to our list!

What Are the Options for Treatment-Resistant Depression?

 

Despite the causes of treatment-resistant depression, if you have it you are not alone. Roughly one -third of patients continue to experience symptoms of depression even after trying two medications, and many don't respond to medication at all.

 

However, there are meaningful steps you can take toward a better quality of life, even if genes are affecting your response to medications. Non-drug treatments exist that are entirely unaffected by any genetic variations that may be governing your body's reaction to medications.

 

Transcranial magnetic stimulation (TMS) is one non-drug, non-invasive therapy option. TMS applies gentle magnetic pulses to brain regions that are crucial to mood regulation. TMS is FDA-cleared for use when one medication has not been effective (but covered by most insurance after two).

 

Even if genes are interfering with the effectiveness of medications, those genes do not decide your future. Whichever treatment avenue you choose, there are empowering ways to manage the depression you're experiencing and find relief from your symptoms.

Let's see if we might be a good fit

Take our short quiz to see if TMS therapy or nasal esketamine could be right for you

Take the quiz

Share this post

We're Better Together

Subscribe for mental health, self-care, and TMS therapy and nasal esketamine updates for those affected by treatment-resistant depression or OCD.

Contact Us

By providing your email address, you are consenting to receive blog updates from Greenbrook TMS Inc. You may unsubscribe from these alerts at any time by following the “unsubscribe” link at the bottom of email alerts. At Greenbrook TMS Inc. we take the privacy and security of your personal information seriously. To learn more about how we protect your personal information, please refer to our Privacy Policy.

You might also like

June 3, 2025
By: Joe Morales Manager of Regional Operations,  Greenbrook Mental Wellness Centers
May 27, 2025
By: Sonnita "Sunny" Pruitt Senior Behavioral Health Technician Greenbrook Mental Wellness Centers
By Caroline Wing May 23, 2025
By: Katie Osborne Behavioral Health Technicial Greenbrook Mental Wellness Centers
May 20, 2025
Written By: Sean Blackburn Greenbrook Alumnus